Skip to Main Content

Author Details

Christer Busch
Uppsala University
1970
173
46
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36268078AI-based prostate analysis system trained without human supervision to predict patient outcome from tissue samples.J Pathol Inform2022
30575473Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up.N Engl J Med2018
29464029The protein kinase SIK downregulates the polarity protein Par3.Oncotarget2017
25756394TGFβ-induced phosphorylation of Par6 promotes migration and invasion in prostate cancer cells.Br J Cancer2015
26237329Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer.PLoS One2015
24597866Radical prostatectomy or watchful waiting in early prostate cancer.N Engl J Med2014
24570393Stem cell marker-positive stellate cells and mast cells are reduced in benign-appearing bladder tissue in patients with urothelial carcinoma.Virchows Arch2014
23322760Blind color decomposition of histological images.IEEE Trans Med Imaging2013
23766933Histological stain evaluation for machine learning applications.J Pathol Inform2013
23470167Tumour expression of bladder cancer-associated urinary proteins.BJU Int2013
22684152Microarray core detection by geometric restoration.Anal Cell Pathol (Amst)2012
21156335Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993).Eur Urol2011
21980608Simplification of grading papillary urothelial neoplasia using a reduced set of diagnostic features.Anal Quant Cytol Histol2011
21980609Diagnosis of intraurothelial neoplasia. Interobserver variation and the value of individual histopathologic attributes.Anal Quant Cytol Histol2011
21542742Radical prostatectomy versus watchful waiting in early prostate cancer.N Engl J Med2011
19821490Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma.Int J Cancer2010
20647401The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes.Cancer Epidemiol Biomarkers Prev2010
20409773COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67.Cancer Epidemiol2010
19154461Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study.BJU Int2009
19450827Personalized prediction of tumor response and cancer progression on prostate needle biopsy.J Urol2009
19164922Pro-apoptotic effect of aurothiomalate in prostate cancer cells.Cell Cycle2009
18695132Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.J Natl Cancer Inst2008
18510570The prognostic impact of M-CSF, CSF-1 receptor, CD68 and CD3 in prostatic carcinoma.Histopathology2008
17130098Prediction of percent Gleason grade 4/5 by multiple core biopsies.Scand J Urol Nephrol2006
15790698Significant expression of IGFBP2 in breast cancer compared with benign lesions.J Clin Pathol2005
16399417Low-grade Ta (noninvasive) urothelial carcinoma of the bladder.Urology2005
16399414Bladder cancer: epidemiology, staging and grading, and diagnosis.Urology2005
16257840The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer.Scand J Urol Nephrol2005
16257839Prediction of the volume of large prostate cancers by multiple core biopsies.Scand J Urol Nephrol2005
15888698Radical prostatectomy versus watchful waiting in early prostate cancer.N Engl J Med2005
14694530A fluid cover medium provides superior morphology and preserves RNA integrity in tissue sections for laser microdissection and pressure catapulting.J Pathol2004
12684767Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium.Virchows Arch2003
14501720No increased prostate cancer incidence after negative transrectal ultrasound guided multiple biopsies in men with increased prostate specific antigen and/or abnormal digital rectal examination.J Urol2003
11979369Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition.Hum Pathol2002
12189498The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems.Virchows Arch2002
12226148A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.N Engl J Med2002
12082297Automatic registration and error detection of multiple slices using landmarks.Anal Cell Pathol2001
11257652Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy.J Urol2001
10700002Cultured human fibroblasts in agarose gel as a multi-functional control for immunohistochemistry. Standardization Of Ki67 (MIB1) assessment in routinely processed urinary bladder carcinoma tissue.J Pathol2000
10937051Paraffin section storage and immunohistochemistry. Effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen.Appl Immunohistochem Mol Morphol2000
11144906Intraepithelial lesions of urinary bladder: morphologic considerations.Scand J Urol Nephrol Suppl2000
10565748Biopsy protocol stability in a three-dimensional model of prostate cancer: changes in cancer yield after adjustment of biopsy positions.Urology1999
10458347Recurrence and progression in low grade papillary urothelial tumors.J Urol1999
10226518Comparison of comparative genomic hybridization, fluorescence in situ hybridization and flow cytometry in urinary bladder cancer.Anticancer Res1999
10221264Distribution of prostasomes in neoplastic epithelial prostate cells.Prostate1999
100818525-year followup of a randomized prospective study comparing mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma. Swedish-Norwegian Bladder Cancer Study Group.J Urol1999
9886611Three-dimensional computer reconstruction of prostate cancer from radical prostatectomy specimens: evaluation of the model by core biopsy simulation.Urology1999
10569619Activity of standard and investigational cytotoxic drugs in primary cultures of tumor cells from patients with kidney and urinary bladder carcinomas.J Urol1999
10604734Automatic quantification of microvessel density in urinary bladder carcinoma.Br J Cancer1999
10604703Modeling prostate cancer distributions.Urology1999
  • 1 - 50 of 173

Recommended Authors

Medical University of Innsbruck
Career Start Year 1999
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 4
Schulich School of Medicine and Dentistry, University of Western Ontario
Career Start Year 1989
Number of shared co-authors 1
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 2
PolyClinic St. Moritz/Scuol
Career Start Year 1986
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 1986
Number of shared co-authors 4
Eastern Virginia Medical School
Career Start Year 1985
Number of shared co-authors 0
University of Kansas
Career Start Year 1985
Number of shared co-authors 1
Duke School of Medicine
Career Start Year 1984
Number of shared co-authors 0
University of Applied Sciences (HTW) Berlin
Career Start Year 1983
Number of shared co-authors 0
Queen's University
Career Start Year 1982
Number of shared co-authors 2
University of Pittsburgh School of Medicine
Career Start Year 1982
Number of shared co-authors 0
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 1
European Hospital Georges Pompidou, University of Paris Descartes
Career Start Year 1982
Number of shared co-authors 0
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 5
University of Oxford, John Radcliffe Hospital
Career Start Year 1981
Number of shared co-authors 6
Mayo Clinic
Career Start Year 1980
Number of shared co-authors 2
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 1
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 4
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 2
The Institute of Cancer Research
Career Start Year 1978
Number of shared co-authors 4
Dartmouth-Hitchcock Medical Center
Career Start Year 1978
Number of shared co-authors 0
Purdue University
Career Start Year 1978
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 1977
Number of shared co-authors 2
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 2
University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 2
CHU de Quebec-Universite Laval
Career Start Year 1975
Number of shared co-authors 2
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 7
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 3

Collaborators

Uppsala University
Co-authored papers 21
Karolinska Institute
Co-authored papers 16
Uppsala University
Co-authored papers 6
Co-authored papers 3
KTH Royal Institute of Technology
Co-authored papers 2
Uppsala University
Co-authored papers 2
Texas A&M Health Science Center Institute of Biosciences and Technology
Co-authored papers 2
Co-authored papers 1
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers 1
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 1
KTH Royal Institute of Technology
Co-authored papers 1
Mount Sinai Hospital
Co-authored papers 1
Co-authored papers 1
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers 1
KTH Royal Institute of Technology
Co-authored papers 1
Uppsala University
Co-authored papers 1
Uppsala University
Co-authored papers 1
Weill Medical College of Cornell University
Co-authored papers 1
OncoMark Ltd
Co-authored papers 1
Karolinska Institute
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Cedars-Sinai Medical Center
Co-authored papers 1
Uppsala University
Co-authored papers 1
Lund University
Co-authored papers 1
Uppsala University
Co-authored papers 1
Skane University Hospital, Lund University
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Division of Clinical Genetics, Lund University
Co-authored papers 1
KTH Royal Institute of Technology and Science for Life Laboratories
Co-authored papers 1